Johnson & Johnson

NYSE: JNJ
$163.20
-$0.16 (-0.1%)
Closing price October 3, 2022
Playing it safe just makes sense now for worried investors, until the Federal Reserve is done raising interest rates. These six Warren Buffett favorite picks surely will hold up better than many...
Corporate boards are approving new share repurchase programs in order to beat an end-of-the-year deadline to beat the new 1% excise tax.
Many experts see the markets retreating 20% or more in the coming weeks. These seven picks from Warren Buffett's Berkshire Hathaway portfolio make sense in these volatile times, as they are...
With interest rates rising and inflation stripping bond yields to zilch, these seven Dividend King stocks offer outstanding safety and total return potential for worried growth and income investors...
Often when total return investors look for companies paying big dividends, they are drawn to the Dividend Kings, which have raised the dividends they pay for at least 50 consecutive years. Three of...
In a market that is very volatile and could be headed much lower if we are actually in a recession, these four safe Dividend Aristocrats and Warren Buffet Berkshire Hathaway stocks with upside...
Here are previews of five companies set to report quarterly results late Monday or early Tuesday, including IBM and Johnson & Johnson.
Given the market's nervousness, Stifel's strategy now is to go with defensive value stocks and selected growth stocks. These nine top picks fit the bill, as they are Buy-rated across Wall Street and...
With the potential for a sizable correction looming, 24/7 Wall St. thought it would be a good idea to look for Dividend Aristocrats that are in defensive sectors but look poised to do well the rest...
These five top companies are expected to lift the dividends they pay to shareholders this week, making their stocks good total return candidates.
Markets are closed Friday, so this earnings preview looks ahead to four companies reporting results before markets open on Tuesday.
With even moderate appreciation in these five safe Dividend King stocks, growth and income investors should be looking at double-digit total return potential. Given the current turmoil in the...
With the potential for a sizable correction looming, here are five Dividend Aristocrats that are in sectors that are defensive and that are poised to do well the rest of 2022. With even moderate...
Analysts at Jefferies have a dividend playbook for the rest of 2022. They consider these eight blue-chip stock picks in a variety of sectors to have "rock solid" dividends that are unlikely to be cut...
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.